• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外源性皮质类固醇所致骨质流失的可逆性。

Reversibility of exogenous corticosteroid-induced bone loss.

作者信息

Rizzato G, Montemurro L

机构信息

Sarcoid Clinic, Niguarda Hospital, Milan, Italy.

出版信息

Eur Respir J. 1993 Jan;6(1):116-9.

PMID:8425581
Abstract

Osteoporosis is not usually considered to be reversible, as it is a consequence of the ageing process. However, an improvement of bone mineral density after successful surgery in Cushing's syndrome has been shown in several reports. The question of reversibility of exogenous corticosteroid-induced osteoporosis is, as yet, unanswered, possibly because of the difficulty in discontinuing steroids after long-term use. We describe six patients, all under 45 yrs of age, with chronic long-standing sarcoidosis, in whom long-term prednisone therapy resulted in 15 +/- 7% bone loss, as evaluated by quantitative computed tomography. This side-effect appeared fully reversible after prednisone withdrawal. This report of the reversibility of exogenous corticosteroid-induced bone loss needs confirmation in elderly people, where the capacity for recovery of bone mass could be reduced. Such potential for recovery may have implications for the pattern of use of corticosteroids.

摘要

骨质疏松症通常被认为是不可逆的,因为它是衰老过程的结果。然而,几份报告显示,库欣综合征患者成功手术后骨矿物质密度有所改善。外源性皮质类固醇所致骨质疏松症的可逆性问题至今尚无答案,这可能是因为长期使用类固醇后难以停药。我们描述了6例年龄均在45岁以下的慢性长期结节病患者,通过定量计算机断层扫描评估,长期泼尼松治疗导致他们骨质流失15±7%。停用泼尼松后,这种副作用似乎完全可逆。外源性皮质类固醇所致骨质流失的这种可逆性报告需要在老年人中得到证实,因为老年人的骨量恢复能力可能会降低。这种恢复潜力可能会对皮质类固醇的使用模式产生影响。

相似文献

1
Reversibility of exogenous corticosteroid-induced bone loss.外源性皮质类固醇所致骨质流失的可逆性。
Eur Respir J. 1993 Jan;6(1):116-9.
2
Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women.泼尼松诱发的结节病骨质流失:一种在绝经后女性中尤为常见的风险。
Sarcoidosis. 1988 Sep;5(2):93-8.
3
Researching osteoporosis in prednisone treated sarcoid patients.研究泼尼松治疗的结节病患者中的骨质疏松症。
Sarcoidosis. 1987 Mar;4(1):45-8.
4
Natural and corticosteroid-induced osteoporosis in sarcoidosis: prevention, treatment, follow up and reversibility.结节病中的自然性和皮质类固醇诱导的骨质疏松症:预防、治疗、随访及可逆性
Sarcoidosis. 1990 Sep;7(2):89-92.
5
The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
Respir Med. 1997 Sep;91(8):449-60. doi: 10.1016/s0954-6111(97)90109-8.
6
Bone loss in prednisone treated sarcoidosis: a two-year follow-up.泼尼松治疗结节病中的骨质流失:两年随访
Ann Ital Med Int. 1990 Jul-Sep;5(3 Pt 1):164-8.
7
[Long-term corticosteroid therapy as a risk factor of osteoporosis in patients with asthma and chronic bronchitis].[长期使用皮质类固醇疗法作为哮喘和慢性支气管炎患者骨质疏松症的一个风险因素]
Pneumonol Alergol Pol. 1996;64(3-4):196-203.
8
Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.用鲑鱼降钙素预防结节病患者皮质类固醇诱导的骨质疏松症。
Calcif Tissue Int. 1991 Aug;49(2):71-6. doi: 10.1007/BF02565124.
9
Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis.鲑鱼降钙素(sCT)在慢性结节病长期类固醇治疗中对骨骼的保护作用。
Sarcoidosis. 1988 Sep;5(2):99-103.
10
Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.在糖皮质激素诱导的骨质疏松症患者中,停用甲状旁腺激素治疗后,髋部骨量仍持续增加:一项随机对照临床试验的结果
J Bone Miner Res. 2000 May;15(5):944-51. doi: 10.1359/jbmr.2000.15.5.944.

引用本文的文献

1
Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.结节病患者椎骨和非椎骨骨折的风险:一项基于人群的队列研究。
Osteoporos Int. 2016 Apr;27(4):1603-1610. doi: 10.1007/s00198-015-3426-1. Epub 2015 Dec 2.
2
Goldilocks, vitamin D and sarcoidosis.金发姑娘、维生素D与结节病
Arthritis Res Ther. 2014;16(3):111. doi: 10.1186/ar4568.
3
Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients.结节病中的骨脆性及其与钙代谢紊乱的关系:一项针对142例患者的横断面研究
Arthritis Res Ther. 2014 Mar 24;16(2):R78. doi: 10.1186/ar4519.
4
Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.糖皮质激素诱导的脊柱骨质疏松症:病理生理学与治疗的科学进展
Eur Spine J. 2006 Jul;15(7):1035-49. doi: 10.1007/s00586-005-0056-x.
5
Clinical impact of bone and calcium metabolism changes in sarcoidosis.结节病中骨与钙代谢变化的临床影响
Thorax. 1998 May;53(5):425-9. doi: 10.1136/thx.53.5.425.
6
Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma.吸入性糖皮质激素对哮喘患者骨密度和骨代谢影响的横断面研究。
Thorax. 1997 Oct;52(10):853-60. doi: 10.1136/thx.52.10.853.